M&A Deal Summary |
|
|---|---|
| Date | 2013-07-24 |
| Target | Epax AS |
| Sector | Life Science |
| Buyer(s) | FMC |
| Sellers(s) | Trygg Pharma |
| Deal Type | Divestiture |
| Deal Value | 345M USD |
SEARCH BY
FMC is an American chemical manufacturing company. It is a diversified chemical company serving agricultural, industrial, environmental, and consumer markets globally for more than a century with innovative solutions, applications and quality products. FMC was incorporated in 1883 and is based in Philadelphia, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 9 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 2 of 5 |
| Country: Norway M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-01 |
GAT Microencapsulation
Ebenfurth, Austria GAT Microencapsulation is a recognized microencapsulation specialist focusing on the stabilization of sensitive active ingredients in the fields of plant protection. GAT Microencapsulation is based in Ebenfurth, Austria. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-13 |
PeroxyChem
Philadelphia, Pennsylvania, United States PeroxyChem LLC is a provider in peroxygen and adjacent chemistries with facilities in North America, Europe, and Asia. PeroxyChem manufactures high-quality products and innovative applications developed as a result of ingenuity and technical expertise. PeroxyChem LLC is based in Philadelphia, Pennsylvania. |
Sell | $200M |
Trygg Pharma is a Norwegian-based 50/50 joint venture with Aker BioMarine. TPH is a manufacturer of marine-based omega-3 EPA/DHA concentrates for nutraceutical and pharmaceutical applications. EPAX, TPH’s nutraceutical division, is a long-standing leader in marine-based omega-3 EPA/DHA fatty acid concentrates for nutraceutical manufacturers and marketers, with a focus on the high concentrate segment. Trygg Pharma, TPH’s pharmaceutical division, is completing a Phase III FDA study on an omega-3-based drug candidate for hypertriglyceridemia. Trygg Pharma was founded in 2009 and is based in Oslo, Norway.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Norway M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-09-03 |
Epax AS
Oslo, Norway Epax is a manufacturer of bulk marine Omega-3 oils for use in dietary supplements and functional foods. Epax was the former industrial brands division of Pronova Biocare and this divison was demerged from Pronova in December 2005. |
Buy | - |
